Literature DB >> 2554505

Chemical and biological heterogeneity in low molecular weight heparins: implications for clinical use and standardization.

J Fareed1, J M Walenga, D Hoppensteadt, A Racanelli, E Coyne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2554505     DOI： 10.1055/s-2007-1002744

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  4 in total

1.  Low-dose and heparin-free hemodialysis in children.

Authors:  D F Geary; M Gajaria; S Fryer-Keene; J Willumsen
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

Review 2.  Critical care in uraemic children.

Authors:  J U Leititis; M Brandis
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

Review 3.  Low molecular weight heparins. An objective overview.

Authors:  D Hoppensteadt; J M Walenga; J Fareed
Journal:  Drugs Aging       Date:  1992 Sep-Oct       Impact factor: 3.923

Review 4.  Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders.

Authors:  J E Frampton; D Faulds
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.